Given the progressive nature of this disease, characterized by gradual impairment in β-cell function and loss of β-cell mass, most patients with type 2 diabetes will eventually require insulin therapy to achieve a goal A1C of < 7%.
Approximately 30% of PCPs never/rarely intensify insulin therapy versus 4% of specialists; the reason may be lack of experience or lack of time to educate people .